Clinical Trial Update: Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

This entry reports results posting for a Phase II trial evaluating adjuvant cisplatin and radiation with pembrolizumab in patients with resected head and neck s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Trisha Wise-Draper | Conditions: Head and Neck Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-05-06